# Kopran Ltd (KOPRAN) > Exchange: NSE | Sector: Pharma | ISIN: ## Price Current Price: ₹167.25 Day Change: +0.05% 52W High: ₹212.58 52W Low: ₹107 Market Cap: ₹832 Cr ## Valuation P/E: 50.36 P/B: 1.66 EPS: ₹3.42 Book Value: ₹104.02 Dividend Yield: 0% ## Returns 1Y Return: 9.25% ## Profitability ROE: 0% ROCE: 15.96% Debt/Equity: 0.31 Revenue Growth: 16.9% Profit Growth: -10.2% EBITDA Margin: 8.95% Operating Margin: 8.14% ## About Kopran Ltd is a Drug Manufacturers - General company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place. Sector: Pharma Industry: Drug Manufacturers - General Sub Industry: Unknown ## Business Model Overview: Kopran Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - General. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma. Source: Derived from stock data Revenue Streams: - Domestic formulations - Exports and regulated markets - Specialty or institutional sales Operating Model: - Develops, manufactures, distributes, or services healthcare products across regulated channels. - Approvals, product mix, compliance quality, and R&D productivity shape growth. Recent Context: - Announcement: Notice Of Shareholders Meeting To Be Held On June 03, 2026 - Quarterly Report: Board Meeting Intimation for Audited Financial Results Q4 FY 2025-26 And Dividend, If Any. - BSE Filing: Notice Of Shareholders Meeting To Be Held On June 03, 2026 ## Access Current tier: anonymous More history: Register free to see 13 more years. ## Data Freshness Quote Updated: 2026-05-21T20:00:02.224Z Price History Updated: 2026-05-18T22:59:14.688Z Latest Price History Date: 2026-05-18 Technicals Updated: 2026-05-18T22:59:14.688Z Quant Updated: 2026-05-18T22:59:14.688Z Sentiment Updated: 2026-05-18T22:59:14.688Z Financials Status: current Financials Updated: 2026-05-19T12:32:01.363Z Financials Last Attempt: 2026-05-19T12:32:01.363Z Financials Provider Tried: yahoo Latest P&L Period: FY25 Latest Balance Sheet Period: FY25 Latest Cash Flow Period: FY25 ## P&L (FY25) Revenue: ₹623.99 Cr Operating Profit: ₹57.31 Cr (OPM 9.18%) Net Profit: ₹38.55 Cr Tax: ₹13.4 Cr ## Annual P&L History FY25: Rev ₹623.99Cr | PAT ₹38.55Cr | OPM 9.18% FY24: Rev ₹610.09Cr | PAT ₹50.96Cr | OPM 10.09% FY23: Rev ₹548.18Cr | PAT ₹27.23Cr | OPM 8.26% ## Balance Sheet (FY25) Total Assets: ₹844.01 Cr Total Liabilities: ₹325.66 Cr Borrowings: ₹147.79 Cr Cash: ₹19.47 Cr ## Shareholding undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% ## Board - Surendra Shrikrishna Somani B.Com., Chairman & MD - Basant Kumar Soni, Chief Financial Officer - Sunil Radheyshyam Sodhani, Company Secretary & Compliance Officer - Ajit Jain FCA, Chief Operating Officer - Vandana Somani, Director --- Source: rupiya.io/stocks/kopran Disclaimer: For research and education only. Not investment advice.